Define: A Study of Entecavir VS Adefovir VS the Combination In Lamivudine-Refractory Chronic Hepatitis B Patients Trademark Details

This mark is dead with a status of Abandoned-Failure to Respond or Late Response. The last case file activity for this mark occured 12 years ago on Monday, August 8, 2011, according to the United State Patent & Trademark Office
Word Mark Define: a Study of Entecavir Vs Adefovir Vs the Combination in Lamivudine-Refractory Chronic Hepatitis B Patients
Status Dead 602 — Abandoned-Failure to Respond or Late Response

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77056234
Status Date Monday, August 8, 2011
Filing Date Monday, August 8, 2011
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Case File Statements

Disclaimer with Predetermined Text "a Study of Entecavir Vs Adefovir Vs the Combination in Lamivudine-Refractory Chronic Hepatitis B Patients"
Goods & Services Medical and Scientific Research, Namely, Conducting Clinical Trials Relating to Pharmaceutical Preparations for Human Use

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Thursday, December 7, 2006
First Use Anywhere Monday, March 31, 2008
First Use In Commerce Monday, March 31, 2008
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.